SCHEMBL7979855

SCHEMBL7979855

COC(=O)C1Cc2ccsc2CN1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
PNMT P11086 1/20 0.36
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
BACE1 P56817 1/20 0.34
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24184649 1.00 KMT2A (0.48) KMT2AALDH1A1MAPTKDM4EHSD17B10
Hydrochloric Acid SCHEMBL9789720 0.98 KMT2A (0.47) KMT2AALDH1A1MAPTKDM4EHSD17B10
SCHEMBL23480476 0.89 KMT2A (0.49) KMT2AALDH1A1MAPTKDM4EHSD17B10
Hydrochloric Acid SCHEMBL9789645 0.88 KMT2A (0.48) KMT2AALDH1A1MAPTKDM4EHSD17B10
Hydrochloric Acid SCHEMBL9789700 0.88 KMT2A (0.48) KMT2AALDH1A1MAPTKDM4EHSD17B10
Hydrochloric Acid SCHEMBL9789713 0.88 KMT2A (0.48) KMT2AALDH1A1MAPTKDM4EHSD17B10
SCHEMBL8552744 0.87 KMT2A (0.39) KMT2AALDH1A1MAPTKDM4EHSD17B10
SCHEMBL21899389 0.82 EGLN1 (0.47) KMT2AMAPTGAAPNMTMEN1
SCHEMBL7966594 0.82 EGLN1 (0.47) KMT2AMAPTGAAPNMTMEN1
Hydrochloric Acid SCHEMBL8384193 0.81 EGLN1 (0.46) KMT2AMAPTGAAPNMTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323215-B1 TREAT AND PREVENT DISORDERS CHARACTERIZED BY NEURONAL DAMAGE SUCH AS PARKINSON'S DISEASE, ALZHEIMER'S DISEASE, STROKE, MULTIPLE SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS, DIABETIC NEUROPATHY AND BELL'S PALSY. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-11-27 US disclosed